Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_assertion type Assertion NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_head.
- NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_assertion description "[We investigated the molecular factors and pathway activation signatures that determine sensitivity to c-MET inhibitors in a panel of glioblastoma and medulloblastoma cells, glioblastoma stem cells, and established cell line-derived xenografts using functional assays, reverse protein microarrays, and in vivo tumor volume measurements, but validation with animal survival analyses remains to be done.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_provenance.
- NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_assertion evidence source_evidence_literature NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_provenance.
- NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_assertion SIO_000772 23386689 NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_provenance.
- NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_assertion wasDerivedFrom befree-2016 NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_provenance.
- NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_assertion wasGeneratedBy ECO_0000203 NP1050755.RA5sHkqdcRo2lvJlgZzsiHZTj2gjRyr70ciyhnL6t2_KE130_provenance.